{
  "main_header": {
    "sid": 798135,
    "name": "Oxygenta Pharma",
    "stock_name": "Oxygenta Pharma",
    "full_name": "Oxygenta Pharmaceutical Ltd",
    "name_url": "stocks-analysis/oxygenta-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "77.00",
    "chg": -1,
    "chgp": "-1.28%",
    "dir": -1,
    "prev_price": "78.00",
    "mcapval": "289.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524636,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE102E01018",
    "curr_date": "Apr 11, 12:48 PM",
    "curr_time": "01:27 AM",
    "bse_nse_vol": "1.79 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/oxygenta-pharma-798135-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Oxygenta Pharmaceutical Faces Intense Selling Pressure Amid Significant Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-faces-selling-pressure-declines-5-35-amid-significant-losses-1606249",
        "imagepath": "",
        "date": "2025-03-26 13:35:10",
        "description": "Oxygenta Pharmaceutical Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced consecutive days of losses, falling by 5.35% in today's trading session, which starkly contrasts with the Sensex's decline of just 0.65%. Over the past week, Oxygenta has seen a slight decrease of 0.31%, while the Sensex gained 2.73%. \n\nIn the last month, Oxygenta's performance has been down by 1.59%, compared to a 3.89% increase in the Sensex. More notably, the stock has dropped 16.47% over the past three months, while the Sensex has only declined by 1.23%. Despite a remarkable 165.06% increase over the past year, the stock has underperformed year-to-date, down 12.24% against the Sensex's minor decline of 0.81%.\n\nToday's trading saw Oxygenta hit an intraday low of Rs 76.76, and it has underperformed its sector by 4.55%. The stock's moving averages indicate a tre..."
      },
      {
        "title": "Oxygenta Pharmaceutical Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-faces-significant-selling-pressure-with-1-90-daily-loss-and-15-84-decline-over-three-months-1452665",
        "imagepath": "",
        "date": "2025-03-19 09:35:28",
        "description": "Oxygenta Pharmaceutical Ltd is currently facing significant selling pressure, with today's trading session showing only sellers in the market. The stock has experienced consecutive losses, falling by 1.90% today alone, which adds to a two-day decline totaling 4.44%. This performance starkly contrasts with the Sensex, which has gained 0.12% today.\n\nOver the past week, Oxygenta has seen a decrease of 2.04%, while the Sensex has risen by 1.84%. The stock's performance over the past month reflects a decline of 4.34%, compared to a slight drop of 0.72% in the Sensex. More notably, Oxygenta's three-month performance shows a significant downturn of 15.84%, against the Sensex's decline of 4.83%.\n\nDespite a remarkable one-year performance of 168.66%, Oxygenta has struggled year-to-date, down 11.51%, while the Sensex has only dipped by 3.51%. The stock remains above its 200-day moving average but is below its shorter..."
      },
      {
        "title": "Oxygenta Pharmaceutical Faces Intense Selling Pressure Amid Ongoing Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-faces-significant-selling-pressure-with-11-93-decline-over-three-months-2-1438641",
        "imagepath": "",
        "date": "2025-03-18 10:10:40",
        "description": "Oxygenta Pharmaceutical Ltd is currently facing significant selling pressure, with today's trading session showing only sellers in the market. This trend marks a continuation of consecutive days of losses, raising concerns among market observers. Over the past week, Oxygenta has underperformed the Sensex, with a decline of 2.02% compared to the Sensex's 1.15% gain. \n\nIn the last month, Oxygenta's performance has also been negative, down 1.89%, while the Sensex fell by a lesser 1.33%. The three-month performance reveals a more pronounced decline for Oxygenta at -11.93%, against the Sensex's -6.52%. Despite a remarkable one-year performance of 171.27%, the stock has seen a year-to-date decline of 7.40%, compared to the Sensex's -4.08%. \n\nPotential contributing factors to the selling pressure may include market volatility and sector-specific challenges within the pharmaceuticals and drugs industry. The stock's..."
      },
      {
        "title": "Oxygenta Pharmaceutical Faces Intense Selling Pressure Amidst Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-faces-selling-pressure-with-1-91-decline-amid-ongoing-losses-1343208",
        "imagepath": "",
        "date": "2025-03-13 11:25:21",
        "description": "Oxygenta Pharmaceutical Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced consecutive losses over the past two days, declining by 2.39% during this period. Today, Oxygenta's performance is down by 1.91%, contrasting sharply with the Sensex, which has gained 0.18%.\n\nOver the past week, Oxygenta has shown a positive trend with a 3.53% increase, while the Sensex has dipped by 0.24%. However, the longer-term view reveals a decline of 11.63% over the past month, compared to a 2.60% drop in the Sensex. In the three-month period, Oxygenta's performance is down 14.04%, while the Sensex has decreased by 9.71%. \n\nDespite a remarkable 166.60% increase over the past year, the stock has faced challenges year-to-date, with a decline of 11.40%, against the Sensex's 5.09% drop. The stock's current price is above its 5-day and 200-day moving averages b..."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd Sees Significant Buying Activity Amid Strong Long-Term Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-surges-8-17-today-achieves-159-48-yearly-growth-amid-market-volatility-1316979",
        "imagepath": "",
        "date": "2025-03-12 10:35:13",
        "description": "Oxygenta Pharmaceutical Ltd is witnessing significant buying activity today, marking a notable performance in the pharmaceuticals and drugs sector. Over the past week, the stock has gained 8.17%, significantly outperforming the Sensex, which only increased by 0.29%. This surge comes after a challenging month where Oxygenta experienced a decline of 11.27%, while the Sensex fell by 2.92%.\n\nDespite recent volatility, Oxygenta's long-term performance remains impressive, with a remarkable 159.48% increase over the past year, compared to the Sensex's modest 0.37% gain. The stock has also shown substantial growth over three years, rising 251.33%, and an impressive 987.67% over five years, far exceeding the Sensex's performance during the same periods.\n\nToday's trading session opened with a gap up, indicating strong buyer sentiment. The stock is currently trading above its 5-day and 200-day moving averages, althoug..."
      },
      {
        "title": "Oxygenta Pharmaceutical Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-faces-selling-pressure-with-1-99-decline-amid-consecutive-losses-1276097",
        "imagepath": "",
        "date": "2025-03-11 14:25:09",
        "description": "Oxygenta Pharmaceutical Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend is underscored by a series of consecutive losses, as the stock has declined by 13.20% over the past month, contrasting sharply with the Sensex, which has only fallen by 2.82% during the same period. \n\nIn terms of daily performance, Oxygenta has decreased by 1.99%, while the Sensex has remained relatively stable with a minimal change of 0.03%. Over the past week, Oxygenta has seen a notable decline of 10.35%, significantly outpacing the Sensex's 1.58% drop. \n\nDespite a strong performance over the longer term, with a remarkable 987.95% increase over the past five years, the stock's year-to-date performance shows a decline of 9.20%, compared to the Sensex's 5.12% drop. The stock has traded within a narrow range of Rs 0.02 today, and while it is above its 5-day and 200-day moving a..."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd Achieves Five Consecutive Days of Gains Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-surges-1-96-today-achieves-10-32-gain-over-last-week-1272076",
        "imagepath": "",
        "date": "2025-03-11 10:35:12",
        "description": "Oxygenta Pharmaceutical Ltd is currently witnessing significant buying activity, with the stock showing a notable performance today. It has gained 1.96%, contrasting sharply with the Sensex, which has declined by 0.37%. Over the past week, Oxygenta has experienced a robust increase of 10.32%, marking five consecutive days of gains. This trend highlights the stock's resilience, especially when compared to the Sensex's modest weekly performance of 1.16%.\n\nDespite a challenging month where Oxygenta's performance dipped by 13.22%, its year-to-date performance remains relatively stable at -9.23%, compared to the Sensex's -5.50%. Over the longer term, Oxygenta has shown remarkable growth, with a staggering 987.67% increase over five years, significantly outperforming the Sensex's 106.84% in the same period.\n\nThe stock opened at 79.4 today and has maintained this price level, indicating a lack of volatility. Addit..."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd Sees Significant Buying Activity Amidst Strong Yearly Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-rises-1-90-achieves-5-95-weekly-gain-amid-strong-buying-activity-1517254",
        "imagepath": "",
        "date": "2025-03-10 10:35:16",
        "description": "Oxygenta Pharmaceutical Ltd is currently witnessing significant buying activity, marking a notable performance in the pharmaceuticals and drugs sector. The stock has gained 1.90% today, outperforming the Sensex, which has only increased by 0.32%. Over the past week, Oxygenta has shown a robust performance with a total increase of 5.95%, compared to the Sensex's 2.03%.\n\nThe stock has been on a positive trajectory for the last four consecutive days, accumulating an impressive 8.1% return during this period. Despite a challenging month where it declined by 15.43%, Oxygenta's year-to-date performance reflects a decrease of 11.06%, while it has achieved a remarkable 129.97% increase over the past year.\n\nToday, Oxygenta opened at 77.8 and has maintained this price level throughout the trading session. The stock is currently trading above its 5-day and 200-day moving averages, although it remains below the 20-day,..."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd Sees Strong Buying Activity Amid Positive Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-gains-1-99-today-marks-6-09-increase-over-three-days-1231724",
        "imagepath": "",
        "date": "2025-03-07 10:30:56",
        "description": "Oxygenta Pharmaceutical Ltd is witnessing significant buying activity, marking a notable performance in the pharmaceuticals and drugs sector. The stock has gained 1.99% today, outperforming the Sensex, which only increased by 0.15%. Over the past three days, Oxygenta has shown a consecutive gain of 6.09%, indicating a positive trend in buyer sentiment.\n\nIn terms of broader performance metrics, Oxygenta has delivered a remarkable 125.69% return over the past year, significantly outpacing the Sensex's modest gain of 0.45%. However, the stock has faced challenges in the shorter term, with a decline of 16.14% over the past month compared to the Sensex's drop of 4.37%.\n\nToday's trading saw Oxygenta open at 76.35, maintaining this price throughout the session. The stock is currently positioned higher than its 5-day and 200-day moving averages, although it remains below the 20-day, 50-day, and 100-day moving avera..."
      }
    ],
    "total": 83,
    "sid": "798135",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/oxygenta-pharmaceutical-798135"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "31-Mar-2025",
      "details": "TWC for the Quarter Ending 31st March 2025",
      "source": "BSE"
    },
    {
      "caption": "Updates on Open Offer",
      "datetime": "08-Mar-2025",
      "details": "Mark Corporate Advisors Pvt Ltd. (Manager to the Offer) has submitted to BSE a copy of Post Offer Advertisement under Regulation 18(12) of SEBI (SAST) Regulations 2011 and amendments thereto (SEBI (SAST) Regulations 2011) for the attention of the Public Shareholders of Oxygenta Pharmaceutical Ltd (Target Company).",
      "source": "BSE"
    },
    {
      "caption": "Integrated Filing (Financial)",
      "datetime": "14-Feb-2025",
      "details": "Unaudited financial results for the Quarter ended December 312024.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Oxygenta Pharmaceutical Faces Intense Selling Pressure Amid Significant Price Declines

2025-03-26 13:35:10

Oxygenta Pharmaceutical Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced consecutive days of losses, falling by 5.35% in today's trading session, which starkly contrasts with the Sensex's decline of just 0.65%. Over the past week, Oxygenta has seen a slight decrease of 0.31%, while the Sensex gained 2.73%. In the last month, Oxygenta's performance has been down by 1.59%, compared to a 3.89% increase in the Sensex. More notably, the stock has dropped 16.47% over the past three months, while the Sensex has only declined by 1.23%. Despite a remarkable 165.06% increase over the past year, the stock has underperformed year-to-date, down 12.24% against the Sensex's minor decline of 0.81%. Today's trading saw Oxygenta hit an intraday low of Rs 76.76, and it has underperformed its sector by 4.55%. The stock's moving averages indicate a tre...

Read More

Oxygenta Pharmaceutical Faces Intense Selling Pressure Amid Consecutive Losses

2025-03-19 09:35:28

Oxygenta Pharmaceutical Ltd is currently facing significant selling pressure, with today's trading session showing only sellers in the market. The stock has experienced consecutive losses, falling by 1.90% today alone, which adds to a two-day decline totaling 4.44%. This performance starkly contrasts with the Sensex, which has gained 0.12% today. Over the past week, Oxygenta has seen a decrease of 2.04%, while the Sensex has risen by 1.84%. The stock's performance over the past month reflects a decline of 4.34%, compared to a slight drop of 0.72% in the Sensex. More notably, Oxygenta's three-month performance shows a significant downturn of 15.84%, against the Sensex's decline of 4.83%. Despite a remarkable one-year performance of 168.66%, Oxygenta has struggled year-to-date, down 11.51%, while the Sensex has only dipped by 3.51%. The stock remains above its 200-day moving average but is below its shorter...

Read More

Oxygenta Pharmaceutical Faces Intense Selling Pressure Amid Ongoing Losses

2025-03-18 10:10:40

Oxygenta Pharmaceutical Ltd is currently facing significant selling pressure, with today's trading session showing only sellers in the market. This trend marks a continuation of consecutive days of losses, raising concerns among market observers. Over the past week, Oxygenta has underperformed the Sensex, with a decline of 2.02% compared to the Sensex's 1.15% gain. In the last month, Oxygenta's performance has also been negative, down 1.89%, while the Sensex fell by a lesser 1.33%. The three-month performance reveals a more pronounced decline for Oxygenta at -11.93%, against the Sensex's -6.52%. Despite a remarkable one-year performance of 171.27%, the stock has seen a year-to-date decline of 7.40%, compared to the Sensex's -4.08%. Potential contributing factors to the selling pressure may include market volatility and sector-specific challenges within the pharmaceuticals and drugs industry. The stock's...

Read More

Oxygenta Pharmaceutical Faces Intense Selling Pressure Amidst Consecutive Losses

2025-03-13 11:25:21

Oxygenta Pharmaceutical Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced consecutive losses over the past two days, declining by 2.39% during this period. Today, Oxygenta's performance is down by 1.91%, contrasting sharply with the Sensex, which has gained 0.18%. Over the past week, Oxygenta has shown a positive trend with a 3.53% increase, while the Sensex has dipped by 0.24%. However, the longer-term view reveals a decline of 11.63% over the past month, compared to a 2.60% drop in the Sensex. In the three-month period, Oxygenta's performance is down 14.04%, while the Sensex has decreased by 9.71%. Despite a remarkable 166.60% increase over the past year, the stock has faced challenges year-to-date, with a decline of 11.40%, against the Sensex's 5.09% drop. The stock's current price is above its 5-day and 200-day moving averages b...

Read More

Oxygenta Pharmaceutical Ltd Sees Significant Buying Activity Amid Strong Long-Term Gains

2025-03-12 10:35:13

Oxygenta Pharmaceutical Ltd is witnessing significant buying activity today, marking a notable performance in the pharmaceuticals and drugs sector. Over the past week, the stock has gained 8.17%, significantly outperforming the Sensex, which only increased by 0.29%. This surge comes after a challenging month where Oxygenta experienced a decline of 11.27%, while the Sensex fell by 2.92%. Despite recent volatility, Oxygenta's long-term performance remains impressive, with a remarkable 159.48% increase over the past year, compared to the Sensex's modest 0.37% gain. The stock has also shown substantial growth over three years, rising 251.33%, and an impressive 987.67% over five years, far exceeding the Sensex's performance during the same periods. Today's trading session opened with a gap up, indicating strong buyer sentiment. The stock is currently trading above its 5-day and 200-day moving averages, althoug...

Read More

Oxygenta Pharmaceutical Faces Intense Selling Pressure Amid Consecutive Losses

2025-03-11 14:25:09

Oxygenta Pharmaceutical Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend is underscored by a series of consecutive losses, as the stock has declined by 13.20% over the past month, contrasting sharply with the Sensex, which has only fallen by 2.82% during the same period. In terms of daily performance, Oxygenta has decreased by 1.99%, while the Sensex has remained relatively stable with a minimal change of 0.03%. Over the past week, Oxygenta has seen a notable decline of 10.35%, significantly outpacing the Sensex's 1.58% drop. Despite a strong performance over the longer term, with a remarkable 987.95% increase over the past five years, the stock's year-to-date performance shows a decline of 9.20%, compared to the Sensex's 5.12% drop. The stock has traded within a narrow range of Rs 0.02 today, and while it is above its 5-day and 200-day moving a...

Read More

Oxygenta Pharmaceutical Ltd Achieves Five Consecutive Days of Gains Amid Market Volatility

2025-03-11 10:35:12

Oxygenta Pharmaceutical Ltd is currently witnessing significant buying activity, with the stock showing a notable performance today. It has gained 1.96%, contrasting sharply with the Sensex, which has declined by 0.37%. Over the past week, Oxygenta has experienced a robust increase of 10.32%, marking five consecutive days of gains. This trend highlights the stock's resilience, especially when compared to the Sensex's modest weekly performance of 1.16%. Despite a challenging month where Oxygenta's performance dipped by 13.22%, its year-to-date performance remains relatively stable at -9.23%, compared to the Sensex's -5.50%. Over the longer term, Oxygenta has shown remarkable growth, with a staggering 987.67% increase over five years, significantly outperforming the Sensex's 106.84% in the same period. The stock opened at 79.4 today and has maintained this price level, indicating a lack of volatility. Addit...

Read More

Oxygenta Pharmaceutical Ltd Sees Significant Buying Activity Amidst Strong Yearly Gains

2025-03-10 10:35:16

Oxygenta Pharmaceutical Ltd is currently witnessing significant buying activity, marking a notable performance in the pharmaceuticals and drugs sector. The stock has gained 1.90% today, outperforming the Sensex, which has only increased by 0.32%. Over the past week, Oxygenta has shown a robust performance with a total increase of 5.95%, compared to the Sensex's 2.03%. The stock has been on a positive trajectory for the last four consecutive days, accumulating an impressive 8.1% return during this period. Despite a challenging month where it declined by 15.43%, Oxygenta's year-to-date performance reflects a decrease of 11.06%, while it has achieved a remarkable 129.97% increase over the past year. Today, Oxygenta opened at 77.8 and has maintained this price level throughout the trading session. The stock is currently trading above its 5-day and 200-day moving averages, although it remains below the 20-day,...

Read More

Oxygenta Pharmaceutical Ltd Sees Strong Buying Activity Amid Positive Market Sentiment

2025-03-07 10:30:56

Oxygenta Pharmaceutical Ltd is witnessing significant buying activity, marking a notable performance in the pharmaceuticals and drugs sector. The stock has gained 1.99% today, outperforming the Sensex, which only increased by 0.15%. Over the past three days, Oxygenta has shown a consecutive gain of 6.09%, indicating a positive trend in buyer sentiment. In terms of broader performance metrics, Oxygenta has delivered a remarkable 125.69% return over the past year, significantly outpacing the Sensex's modest gain of 0.45%. However, the stock has faced challenges in the shorter term, with a decline of 16.14% over the past month compared to the Sensex's drop of 4.37%. Today's trading saw Oxygenta open at 76.35, maintaining this price throughout the session. The stock is currently positioned higher than its 5-day and 200-day moving averages, although it remains below the 20-day, 50-day, and 100-day moving avera...

Read More

View All News